Chargement en cours...

Reversible Epigenetic Regulation of 14-3-3σ Expression in Acquired Gemcitabine Resistance by Uhrf1 and DNA Methyltransferase 1

Although gemcitabine is the most commonly used drug for treating pancreatic cancers, acquired gemcitabine resistance in a substantial number of patients appears to hinder its effectiveness in successful treatment of this dreadful disease. To understand acquired gemcitabine resistance, we generated a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Qin, Li, Dong, Zizheng, Zhang, Jian-Ting
Format: Artigo
Langue:Inglês
Publié: The American Society for Pharmacology and Experimental Therapeutics 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201139/
https://ncbi.nlm.nih.gov/pubmed/25189999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.114.092544
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!